Next-Gen Sleep-Tech 'sleepisol+' from Korea to Launch in Japan on June 1, 2026
South Korean sleep-tech firm LEESOL will launch its 'sleepisol+' device in Japan on June 1, 2026. Utilizing proprietary brainwave synchronization technology, it offers a non-pharmacological approach to improving sleep quality.
📋 Article Processing Timeline
- 📰 Published: June 1, 2026 at 13:00
- 🔍 Collected: June 1, 2026 at 13:28 (28 min after Published)
- 🤖 AI Analyzed: June 1, 2026 at 13:29 (0 min after Collected)
LEESOL, a South Korean sleep-tech company, will officially launch its next-generation sleep care device, 'sleepisol+', in the Japanese market on June 1, 2026. Based in Busan with research facilities in Seoul, LEESOL is dedicated to solving neurological challenges through high technology. In Japan, where sleep debt and insomnia are significant social issues, the company aims to offer a new approach distinct from traditional sleeping pills and supplements.
Growing Sleep Issues and Demand in Japan
In Japan, where long working hours and high stress are common, sleep debt is a major social concern. Consequently, the market for sleep improvement—including bedding, supplements, and apps—is expanding rapidly. LEESOL proposes 'sleepisol+' as a new choice based on its proprietary brainwave synchronization technology.
Born from a Founder's Care for His Wife
sleepisol+ is equipped with 'CS-tACS' (Cranial Stimulation-transcranial Alternating Current Stimulation) technology. By applying weak electrical currents to the scalp, it helps improve sleep quality, relaxation, and concentration. It is designed to promote delta waves (under 4Hz), guiding the brain into a 'sleep mode.' The product was originally conceived by CEO Lee Seung-woo to help his wife, who suffered from jet lag and insomnia. The latest model, developed in 2025, has achieved annual sales of approximately 1 billion yen in Korea.
Product Features
The device features four modes: sleep, concentration, stress, and stability. Weighing only 30g, it is designed for comfort and ease of use via a dedicated app. It offers a sustainable, non-pharmacological way to manage sleep conditions.
Clinical Validation
Clinical trials have shown significant improvements in the Insomnia Severity Index (ISI) after six weeks of use. The technology is backed by research and the CES 2025 Innovation Award in the 'Beauty & Personal Care' category.
Future Outlook in Japan
Following a successful crowdfunding campaign in Japan, LEESOL plans to expand through e-commerce, pop-up events, and retail partnerships, targeting both individual consumers and corporate wellness programs.
Growing Sleep Issues and Demand in Japan
In Japan, where long working hours and high stress are common, sleep debt is a major social concern. Consequently, the market for sleep improvement—including bedding, supplements, and apps—is expanding rapidly. LEESOL proposes 'sleepisol+' as a new choice based on its proprietary brainwave synchronization technology.
Born from a Founder's Care for His Wife
sleepisol+ is equipped with 'CS-tACS' (Cranial Stimulation-transcranial Alternating Current Stimulation) technology. By applying weak electrical currents to the scalp, it helps improve sleep quality, relaxation, and concentration. It is designed to promote delta waves (under 4Hz), guiding the brain into a 'sleep mode.' The product was originally conceived by CEO Lee Seung-woo to help his wife, who suffered from jet lag and insomnia. The latest model, developed in 2025, has achieved annual sales of approximately 1 billion yen in Korea.
Product Features
The device features four modes: sleep, concentration, stress, and stability. Weighing only 30g, it is designed for comfort and ease of use via a dedicated app. It offers a sustainable, non-pharmacological way to manage sleep conditions.
Clinical Validation
Clinical trials have shown significant improvements in the Insomnia Severity Index (ISI) after six weeks of use. The technology is backed by research and the CES 2025 Innovation Award in the 'Beauty & Personal Care' category.
Future Outlook in Japan
Following a successful crowdfunding campaign in Japan, LEESOL plans to expand through e-commerce, pop-up events, and retail partnerships, targeting both individual consumers and corporate wellness programs.
FAQ
What is the primary target market in Japan?
The company targets individuals suffering from sleep deprivation and is also looking into corporate wellness programs.